PACS
Next earnings: Aug 10, 2026
Signal
Bearish Setup1!1
Price
1
Move-5.47%Selling pressure
Volume
1
Volume0.9× avgNormal activity
Technical
1
RSIRSI 70Overbought
PRICE
Prev Close
39.65
Open
38.99
Day Range37.48 – 39.53
37.48
39.53
52W Range7.50 – 43.08
7.50
43.08
84% of range
VOLUME & SIZE
Avg Volume
894.2K
FUNDAMENTALS
P/E Ratio
24.2x
EPS (TTM)
Div Yield
No dividend
Quick Read
TrendInsufficient MA data
Momentum
NEUTRAL
rev +21% · 19% gross margin
Valuation
FAIR
P/E 24x vs ~20x sector
Health
WEAK
CR 1.0 (low) · FCF $1.51/sh
Lean Bearish
Key MetricsTTM
Market Cap$5.93B
Revenue TTM$5.43B
Net Income TTM$243.77M
Free Cash Flow$237.05M
Gross Margin19.2%
Net Margin4.5%
Operating Margin7.0%
Return on Equity26.6%
Return on Assets4.3%
Debt / Equity2.99
Current Ratio0.99
EPS TTM$1.55
Alpha SignalsFull Analysis →
What Moves This Stock

Credit performance metrics across specialty finance portfolios (net charge-off rates, non-performing loan ratios)

M&A announcements and integration execution updates given the conglomerate structure and recent growth trajectory

Net interest margin trends as Fed policy shifts affect funding costs and asset yields

Insurance segment organic growth rates and commission margin stability amid distribution channel shifts

Macro Sensitivity
Economic Cycle

high - Diversified financial services exhibit strong cyclical sensitivity. Specialty lending volumes and credit quality correlate directly with GDP growth and employment trends. Insurance distribution revenues depend on commercial activity and consumer spending patterns. Alternative asset management faces redemption pressure during economic downturns as institutional allocators reduce risk exposure. The 0.94 current ratio indicates limited liquidity cushion during stress periods.

Interest Rates

Rising rates present mixed impacts. Specialty finance portfolios benefit from floating-rate asset repricing faster than funding costs, expanding net interest margins. However, higher rates compress loan origination volumes as borrower demand weakens, and increase the present value discount on long-duration fee streams, pressuring valuation multiples. The 27.1x EV/EBITDA suggests the market is pricing in significant growth, making the stock vulnerable to multiple compression if rates rise further and growth expectations moderate.

Key Risks

Regulatory fragmentation across insurance, lending, and asset management creates compliance complexity and potential enforcement actions that could restrict growth or impose penalties

Disintermediation from fintech platforms and direct-to-consumer digital channels eroding traditional insurance distribution and lending market share

Conglomerate discount as public markets increasingly favor pure-play specialists over diversified financial holding companies

Investor Profile

momentum - The 204.9% one-year return and 161.2% three-month surge attract momentum and event-driven investors betting on continued M&A activity, restructuring catalysts, or sector rotation into financials. The -50.6% net income decline alongside massive price appreciation suggests speculative positioning rather than fundamental value. High volatility and 27.1x EV/EBITDA multiple indicate growth-at-any-price sentiment rather than traditional value or income orientation.

Watch on Earnings
Federal Funds Rate trajectory and forward guidance impacting net interest margins and funding costsHigh yield credit spreads (BAMLH0A0HYM2) as leading indicator of specialty finance portfolio stressUnemployment rate trends affecting consumer and commercial borrower credit quality10-year Treasury yield movements driving valuation multiple compression/expansion for fee-based businesses
Health Radar
2 strong4 concern
42/100
Liquidity
0.99Concern
Leverage
2.99Concern
Coverage
13.7xStrong
ROE
26.6%Strong
ROIC
5.5%Concern
Cash
$197MConcern
ANALYST COVERAGE8 analysts
BUY
+20.1%upside to target
L $40.00
Med $45.00consensus
H $52.00
Buy
788%
Hold
113%
7 Buy (88%)1 Hold (13%)0 Sell (-1%)
Full report →
Stock Health
Composite Score
2 of 5 signals bullish
6/10
Technicals
RSI RangeRSI 70 — Overbought, caution
~
Volume
Volume FlowNeutral
~
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 0.99 — liquidity risk
Upcoming Events
EEarnings ReportMay 17, 2026
Tomorrow
DEx-Dividend DateAug 14, 2026
In 90 days
PDividend PaymentSep 10, 2026
In 117 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

UptrendGolden Cross · 50D leads 200D by 30.9%

+9.0% vs SMA 50 · +42.7% vs SMA 200

Momentum

RSI70.3
Overbought — pullback risk
MACD+1.53
Above zero — bullish momentum · expanding
Market Position
Price Levels
52W High
$43.08+14.9%
Current
$37.48
EMA 50
$35.33-5.7%
EMA 200
$26.19-30.1%
52W Low
$7.50-80.0%
52-Week RangeNear 52-week high
$7.5084th %ile$43.08
Squeeze SetupVolume-based
No Clear Setup

Volume distribution is neutral or leaning toward distribution. No compelling squeeze setup based on current money flow data.

20-Day Money Flow
Acc days:3
Dist days:7
Edge:+4 dist
Volume Context
Avg Vol (50D)819K
Recent Vol (5D)
1.7M+108%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 4 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2024
$4.0B
$4.0B$4.0B
$1.48
±1%
Low1
FY2025
$5.3B
$5.3B$5.3B
+33.8%$1.74+17.2%
±2%
Moderate3
FY2026(current)
$5.7B
$5.7B$5.7B
+7.8%$2.21+27.2%
±1%
Moderate4
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryPACS
Last 5Q
-25.4%avg beat
Beat 2 of 5 quartersMissed 3 Estimates rising
+14%
Q2'24
-121%
Q3'24
-29%
Q4'25
-10%
Q1'26
+19%
Q2'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Insider Activity
SEC Filings →
1 Buy/4 SellsNet Selling
Jergensen JoshuaPresident & COO
$1.2M
Mar 13
SELL
Dilsaver Evelyn SDir
$500K
Nov 24
BUY
Mitchell John ToddChief Legal Of…
$4.8M
Nov 24
SELL
Hancock MarkDir
$294.7M
Sep 9
SELL
Murray Jason HulseDir
$294.7M
Sep 9
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
COHEN & STEERS, INC.
9.1M
2
FMR LLC
5.2M
3
BlackRock, Inc.
3.8M
4
Alyeska Investment Group, L.P.
3.0M
5
Crewe Advisors LLC
2.8M
6
AMERICAN CENTURY COMPANIES INC
1.8M
7
AMERIPRISE FINANCIAL INC
1.1M
8
GEODE CAPITAL MANAGEMENT, LLC
1.1M
News & Activity

PACS News

About

No description available.

PeersHealth Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt CapP/ERev GrwMarginELO
PACS
$37.48+0.00%$5.9B1500
$66.13-5.07%$13.0B+12626.1%-14525.8%1500
$94.92-3.79%$12.6B+3288.2%-4239.0%1500
$523.69-3.00%$12.1B+43205.3%-3008.0%1500
$227.72-1.30%$11.7B+6554.5%-2868.8%1500
$57.90-0.86%$11.2B50.3+1459.3%147.7%1500
$76.67-3.79%$10.8B+2325815.3%-19.7%1500
Sector avg-2.54%50.3+398824.8%-4085.6%1500